The microbiome – a novel paradigm in oncology research
5 Sep 2018
The microbiome – a novel paradigm in oncology research
Editor's Choice for August 2018
New important compounds for targeted and immunotherapies for lung cancer
Updates from a range of lung cancer studies
Large B-cell lymphoma: ZUMA-1 trial
Five practice changing shifts in oncology
Pharmacists and precision oncology
Two important pancreatic studies: PRODIGE 24 and PREOPANC
The promise of immunotherapy in head and neck, and prostate cancer
Several important studies for lung cancer
Four studies about relapsed myeloma and advanced disease
Apps and mobile games for the cancer community